trial · primary record
vepdegestrant
Breast Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 11 |
| Primary completion | 2026-09-10 |
| Primary endpoint | Phase 1b: Number of Participants With Dose Limiting Toxicities |
| Registry ID | NCT06125522 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:46.463Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06125522
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.